LDLs induce fibroblast spreading independently of the LDL receptor via activation of the p38 MAPK pathway

被引:7
作者
Dobreva, I
Waeber, G
Mooser, V
James, RW
Widmann, C [1 ]
机构
[1] Univ Lausanne, Inst Biol Cellulaire & Morphol, Lausanne, Switzerland
[2] CHU Vaudois, Dept Med Interne, CH-1011 Lausanne, Switzerland
[3] Univ Hosp, Lipid Lab, Clin Diabet Unit, Geneva, Switzerland
关键词
remodelling; cell spreading; lamellipodia p38; mitogen-activated protein kinase; low density lipoprotein; lipoproteins; low density lipoprotein receptor; fibroblasts;
D O I
10.1194/jlr.M300266-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Because adventitial fibroblasts play an important role in the repair of blood vessels, we assessed whether elevation in LDL concentrations would affect fibroblast function and whether this depended on activation of intracellular signaling pathways. We show here that in primary human fibroblasts, LDLs induced transient activation of the p38 mitogen-activated protein kinase (MAPK) pathway, but not the c-Jun N-terminal kinase MAPK pathway. This activation did not require the recruitment of the LDL receptor (LDLR), because LDL efficiently stimulated the p38 MAPK pathway in human and mouse fibroblasts lacking functional LDLR, and because receptor-associated protein, an LDLR family antagonist, did not block the LDL-induced p38 activation. LDL particles also induced lamellipodia formation and cell spreading. These effects were blocked by SB203580, a specific p38 inhibitor. EM Our data demonstrate that LDLs can regulate the shape of fibroblasts in a p38 MAPK-dependent manner, a mechanism that may participate in wound healing or vessel remodeling as in atherosclerosis.-Dobreva, L, G. Waeber, V. Mooser, R. W. James, and C. Widmann. LDLs induce fibroblast spreading independently of the LDL receptor via activation of the p38 MAPK pathway.
引用
收藏
页码:2382 / 2390
页数:9
相关论文
共 32 条
[1]  
Aplin AE, 2002, J CELL SCI, V115, P2781
[2]   FAMILIAL HYPERCHOLESTEROLEMIA - DEFECTIVE BINDING OF LIPOPROTEINS TO CULTURED FIBROBLASTS ASSOCIATED WITH IMPAIRED REGULATION OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE-ACTIVITY [J].
BROWN, MS ;
GOLDSTEIN, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1974, 71 (03) :788-792
[3]   Plasma apolipoprotein(a) co-deposits with fibrin in inflammatory arthritic joints [J].
Busso, N ;
Dudler, J ;
Salvi, R ;
Péclat, V ;
Lenain, V ;
Marcovina, S ;
Darioli, R ;
Nicod, P ;
So, AK ;
Mooser, V .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (04) :1445-1453
[4]   Regulation of gene expression by SREBP and SCAP [J].
Edwards, PA ;
Tabor, D ;
Kast, HR ;
Venkateswaran, A .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2000, 1529 (1-3) :103-113
[5]  
EZAKI M, 1995, J LIPID RES, V36, P1996
[6]   Atherosclerosis: The road ahead [J].
Glass, CK ;
Witztum, JL .
CELL, 2001, 104 (04) :503-516
[7]   Molecular medicine - The cholesterol quartet [J].
Goldstein, JL ;
Brown, MS .
SCIENCE, 2001, 292 (5520) :1310-1312
[8]   Does the coronary risk factor low density lipoprotein alter growth and signaling in vascular smooth muscle cells? [J].
Gouni-Berthold, I ;
Sachinidis, A .
FASEB JOURNAL, 2002, 16 (12) :1477-1487
[9]   Troglitazone and rosiglitazone inhibit the low density lipoprotein-induced vascular smooth muscle cell growth [J].
Gouni-Berthold, I ;
Berthold, HK ;
Weber, AA ;
Seul, C ;
Vetter, H ;
Sachinidis, A .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2001, 109 (04) :203-209
[10]   Early platelet activation by low density lipoprotein via p38MAP kinase [J].
Hackeng, CM ;
Relou, IAM ;
Pladet, MW ;
Gorter, G ;
van Rijn, HJM ;
Akkerman, JWN .
THROMBOSIS AND HAEMOSTASIS, 1999, 82 (06) :1749-1756